Breast Cancer Management in North Carolina: Updates for 2020

UNC Cancer Network: "Cancer Treatment in North Carolina: Research to Practice" Lecture

Emily Ray, MD, MPH from the UNC Lineberger Breast Oncology group, will describe relevant updates in systemic therapy for breast cancers for health care providers throughout the state of North Carolina.

Points of discussion include:

• The role of genomic assays in determining adjuvant treatment for early stage HR+ breast cancer
• The options for adjuvant therapy in early stage HER2+ breast cancer
• Treatment for metastatic HER2+ breast cancer

Emily Ray, MD, MPH, Assistant Professor Medicine, Division of Oncology
UNC Lineberger Comprehensive Cancer Center / UNC School of Medicine

Register